Sharp To Showcase Cutting-Edge Digital Press Innovations at Printing United Expo 2025
SHC(NASDAQ:SHC) New finishing solutions, specialty color capabilities and scalable production systems highlight Sharp's commitment to empowering print providers MONTVALE, N.J., Sept. 4, 2025 /PRNewswire/ -- Sharp Imaging and Information Company of America (Sharp) will unveil its latest innovations in...
Sotera Health Announces Secondary Offering of Common Stock
SHC(NASDAQ:SHC) CLEVELAND, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC) (the “Company”) today announced the launch of a secondary offering (the “Offering”) of 20,000,000 shares of its common stock, par value $0.01 per share. All 20,000,000 shares are being offered for sale by certain affiliates of Warburg Pincus LLC (“Warburg Pincus”) and GTCR LLC (“GTCR”) as selling stockholders. No other entities, and no individuals, are selling shares in the Offering. The Company is not offering any shares in the Offering and will not receive any of the proceeds from the Offering. The Company will pay the expenses of the Offering pursuant to its obligations under its Amended and Restated Registration Rights Agreement.
Sotera Health Reports Strong Second-Quarter and First-Half 2025 Results
SHCCLEVELAND, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Sotera Health Company (“Sotera Health” or the “Company”) (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare industry, today announced financial results for the three- and six- months ended June 30, 2025.
Sotera Health 'Is Uniquely Insulated From Potential Tariff Policy,' Goldman Sachs Says
SHCGoldman Sachs upgrades Sotera Health to Buy, citing tariff immunity, legal clarity, and exposure to Medtech innovation for future growth.
Analyst Expectations For Sotera Health's Future
SHCGoldman Sachs Upgrades Sotera Health to Buy, Raises Price Target to $17
SHCSotera Health Affirms FY2025 Adj EPS Guidance of $0.70-$0.76 vs $0.74 Est; Affirms FY2025 Sales Guidance of $1.14B-$1.17B vs $1.13B Est
SHCSotera Health Q1 Adj. EPS $0.14 Beats $0.12 Estimate, Sales $254.52M Beat $245.79M Estimate
SHCPiper Sandler Maintains Neutral on Sotera Health, Lowers Price Target to $13
SHCBarclays Maintains Overweight on Sotera Health, Lowers Price Target to $12
SHCSotera's Nelson Labs Launches Rapid Sterility Testing
SHCBarclays Maintains Overweight on Sotera Health, Lowers Price Target to $16
SHCSotera Health Sees FY2025 Adj EPS $0.70-$0.76 vs $0.78 Est; Sees net revenues growth outlook of 4.0% - 6.0% YOY $1.144B-$1.166B vs $1.16B Est
SHCSotera Health Q4 Adj EPS $0.21 Beats $0.20 Estimate, Sales $290.20M Miss $290.88M Estimate
SHCBarclays Maintains Overweight on Sotera Health, Lowers Price Target to $17
SHCCitigroup Maintains Buy on Sotera Health, Raises Price Target to $20
SHCSotera Health Co Reaffirmed Its 2024 Guidance Of Net Revenue Growth Of 4%-6%; Adj. EPS Of $0.67-$0.75 Vs. $0.72 Est.; Sees Capital Expenditures Of $175M-$185M (Priro $205M-$225M)
SHCSotera Health Q3 2024 Adj. EPS $0.17 Misses $0.18 Estimate, Sales $285.468M Beat $278.585M Estimate
SHCA Glimpse of Sotera Health's Earnings Potential
SHCPiper Sandler Initiates Coverage On Sotera Health with Neutral Rating, Announces Price Target of $13
SHCSotera Health Earnings Conference Call Is Coming Up, Here's What You Need To Know
SHCSotera Health (NASDAQ:SHC) will host a conference call at 09:00 AM ET on May 5, 2022, to discuss Q1 2022 earnings results.
